Company news
Guardant Health, Inc. news in 2024
Guardant Health, Inc.'s news releases, calls and decks from 2024, newest first.
COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics
December 18, 2024
Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer
December 17, 2024
Guardant Health to Share New Research Demonstrating Value of Liquid Biopsy Tests, Real-world Data and AI Analytics in Tailoring Treatment Approaches for Breast Cancer at 2024 San Antonio Breast Cancer Symposium
December 8, 2024
Federal Court Jury Issues Unanimous Verdict that Natera Engaged in False Advertising and Unfair Competition in Deliberate Attempt to Damage Guardant Health's Colorectal Cancer Test, Guardant Reveal™
November 24, 2024
Guardant Health Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
November 5, 2024
Guardant Health Named to TIME’s List of the Best Inventions of 2024
October 29, 2024
Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Colorectal Cancer Screening at ACG 2024
October 27, 2024
Roberto A. Mignone Joins Guardant Health Board of Directors
October 23, 2024
Guardant Health to Report Third Quarter 2024 Financial Results on November 6, 2024
October 14, 2024
GOZILA Study Published in Nature Medicine Shows Patients With Advanced Cancer Who Receive Liquid Biopsy-Guided Treatment Using Guardant360 CDx Survive Twice as Long
September 17, 2024
Guardant Health to Share Data at ESMO 2024 Further Demonstrating Strong Performance of Its Precision Oncology Technology in Multiple Advanced Tumor Types
September 12, 2024
Guardant Health and Policlinico Gemelli Announce Partnership to Establish A Dedicated In-House Liquid Biopsy Testing Service in Italy
September 9, 2024
Guardant Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 26, 2024
Guardant Health to Ring the Nasdaq Opening Bell on August 28 to Celebrate the Launch of Shield™ Blood Test for Colorectal Cancer Screening
August 21, 2024
Guardant Health Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
August 6, 2024
Guardant Health COSMOS Study Published in Clinical Cancer Research Validates Utility of Guardant Reveal™ Liquid Biopsy Test for Predicting Recurrence in Colorectal Cancer
August 6, 2024
Guardant Health’s FDA-approved Shield™ Blood Test Now Commercially Available in U.S. as a Primary Screening Option for Colorectal Cancer
July 31, 2024
Guardant Health Outcomes Model Confirms the Public Health Importance of Enhanced Colorectal Cancer Screening Outcomes with High Adherence Strategies
July 31, 2024
Guardant Health’s Shield™ Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening
July 28, 2024
Guardant Health to Report Second Quarter 2024 Financial Results on August 7, 2024
July 23, 2024
Guardant Health Introduces Major Smart Liquid Biopsy Upgrade to Market-Leading Guardant360® Test, Further Extending Its Best-in-Class Performance
July 22, 2024
Dr. Manuel Hidalgo Medina Joins Guardant Health Board of Directors
July 17, 2024
Guardant Health introduces new Guardant360 TissueNext test with nearly 500 biomarkers to identify more treatment options for patients with advanced cancer
June 3, 2024
Guardant Health and Washington University to present study at 2024 ASCO meeting highlighting utility of ctDNA to address racial inequities in the use of targeted therapies and enrollment in clinical trials
June 2, 2024
Guardant Health Named to TIME100 Most Influential Companies
May 30, 2024
Guardant Health to Present Studies at 2024 ASCO Annual Meeting Highlighting Contributions of Its Blood Tests and Real-World Data to Advancing Precision Oncology and Cancer Screening
May 29, 2024
FDA Advisory Committee Panel Strongly Recommends Approval of Shield™ Blood Test for Colorectal Cancer Screening as a Primary Non-Invasive Screening Option
May 22, 2024
Guardant Health Receives EU IVDR Certification for Guardant360® CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic Indications
May 20, 2024
Guardant Health to present real-world data supporting performance of Shield™ blood test for colorectal cancer screening at 2024 Digestive Disease Week
May 15, 2024
Guardant Health Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
May 8, 2024
Guardant Health Surpasses 500 Peer-Reviewed Publications Milestone
May 6, 2024
FDA Advisory Panel Review of Guardant Health’s Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23
April 21, 2024
Guardant Health to Report First Quarter 2024 Financial Results on May 9, 2024
April 17, 2024
Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting
April 2, 2024
Guardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of Medicine
March 12, 2024
New Survey: Patients and Physicians Overwhelmingly Agree Blood Tests Could Help Close the Colorectal Cancer Screening Gap
February 29, 2024
Guardant Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
February 21, 2024
Guardant Health to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
January 31, 2024
Guardant Health to present data at ASCO GI supporting use of liquid biopsy to predict colon cancer recurrence
January 16, 2024
Guardant Health Announces Preliminary Fourth Quarter and Full Year 2023 Results
January 7, 2024
Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North Africa
January 7, 2024
Guardant Health Appoints Terilyn Juarez Monroe as Chief People Officer
January 1, 2024
Calls in 2024
Decks in 2024
- Q3 2024 Earnings Presentation
Earnings · 21 slides · Nov 6, 2024
- Fact Sheet (October 2024)
Fact sheet · 1 slide · October 2024
- Fact Sheet (October 2024)
Fact sheet · 1 slide · October 2024
- Q2 2024 Earnings Presentation
Earnings · 24 slides · Aug 7, 2024
- William Blair 44th Annual Growth Stock Conference (June 2024)
Conference · 30 slides · Jun 4, 2024
- Technical Presentation (May 2024)
Technical · 74 slides · May 23, 2024
- Q1 2024 Earnings Presentation
Earnings · 21 slides · May 9, 2024
- Fact Sheet (March 2024)
Fact sheet · 1 slide · March 2024
- Fact Sheet (March 2024)
Fact sheet · 1 slide · March 2024
- Q4 2023 Earnings Presentation
Earnings · 19 slides · Feb 22, 2024
- J.P. Morgan 42nd Annual Healthcare Conference (January 2024)
Conference · 36 slides · Jan 8, 2024